ES8503503A1 - Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso - Google Patents

Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso

Info

Publication number
ES8503503A1
ES8503503A1 ES532018A ES532018A ES8503503A1 ES 8503503 A1 ES8503503 A1 ES 8503503A1 ES 532018 A ES532018 A ES 532018A ES 532018 A ES532018 A ES 532018A ES 8503503 A1 ES8503503 A1 ES 8503503A1
Authority
ES
Spain
Prior art keywords
delivery system
drug delivery
osmotic drug
osmotic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532018A
Other languages
English (en)
Spanish (es)
Other versions
ES532018A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8503503(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES532018A0 publication Critical patent/ES532018A0/es
Publication of ES8503503A1 publication Critical patent/ES8503503A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ES532018A 1983-05-11 1984-04-27 Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso Expired ES8503503A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (2)

Publication Number Publication Date
ES532018A0 ES532018A0 (es) 1985-03-01
ES8503503A1 true ES8503503A1 (es) 1985-03-01

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532018A Expired ES8503503A1 (es) 1983-05-11 1984-04-27 Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso

Country Status (20)

Country Link
JP (1) JPS6041609A (enrdf_load_stackoverflow)
AT (1) AT397180B (enrdf_load_stackoverflow)
AU (1) AU566110B2 (enrdf_load_stackoverflow)
BE (1) BE898819A (enrdf_load_stackoverflow)
CA (1) CA1222950A (enrdf_load_stackoverflow)
CH (1) CH669329A5 (enrdf_load_stackoverflow)
DE (1) DE3417113A1 (enrdf_load_stackoverflow)
DK (1) DK163910C (enrdf_load_stackoverflow)
ES (1) ES8503503A1 (enrdf_load_stackoverflow)
FR (1) FR2545721B1 (enrdf_load_stackoverflow)
GB (1) GB2140687B (enrdf_load_stackoverflow)
IE (1) IE56515B1 (enrdf_load_stackoverflow)
IL (1) IL71727A (enrdf_load_stackoverflow)
IT (1) IT1178911B (enrdf_load_stackoverflow)
MX (1) MX163518B (enrdf_load_stackoverflow)
NL (1) NL192250C (enrdf_load_stackoverflow)
NO (1) NO170834C (enrdf_load_stackoverflow)
NZ (1) NZ206600A (enrdf_load_stackoverflow)
SE (1) SE455918B (enrdf_load_stackoverflow)
ZA (1) ZA842422B (enrdf_load_stackoverflow)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
ES2037179T3 (es) * 1987-11-25 1993-06-16 American Cyanamid Company Sistema de liberacion sostenida (controlada) para bloqueadores de canales de calcio de dihidropiridina.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
DE69102140T2 (de) * 1990-09-28 1994-09-08 Pfizer Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
ES2158871T3 (es) * 1993-02-23 2001-09-16 Wolfgang Dr Werner Uso de una formulacion de calcio en un medicamento para la aplicacion terapeutica a vacas lecheras que sufren hipocalcemia.
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
EP2283829A1 (en) * 2000-10-30 2011-02-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
JP5666075B2 (ja) * 2003-09-19 2015-02-12 サン・ファーマシューティカル・インダストリーズ・リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｉｍｉｔｅｄ 経口薬送達システム
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
WO2007039132A1 (de) 2005-10-04 2007-04-12 Bayer Healthcare Ag Neue polymorphe form und die amorphe form von 5-chlor-n- ( { ( 5s ) -2-0x0-3-[4-( 3-oxo-4-morpholinyl) - phenyl] -1,3-oxazolidin-5-yl} -methyl) -2- thiophencarboxamid
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
BRPI0925100A2 (pt) * 2009-06-02 2016-07-19 Dow Global Technologies Llc forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
AU2013258273A1 (en) 2012-05-07 2014-11-13 Bayer Pharma Aktiengesellschaft Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
EP3826619A1 (de) 2018-07-24 2021-06-02 Bayer Aktiengesellschaft Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
JP2021532113A (ja) 2018-07-24 2021-11-25 バイエル・アクチエンゲゼルシヤフト 経口投与可能であり、放出を修飾した薬学的投薬形態

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE376851B (enrdf_load_stackoverflow) * 1971-01-13 1975-06-16 Alza Corp
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
DE3417113A1 (de) 1984-11-15
AT397180B (de) 1994-02-25
JPH0575725B2 (enrdf_load_stackoverflow) 1993-10-21
DK99784A (da) 1984-11-12
NO840248L (no) 1984-11-12
GB8334189D0 (en) 1984-02-01
DK163910C (da) 1992-09-14
IT1178911B (it) 1987-09-16
DE3417113C2 (enrdf_load_stackoverflow) 1989-02-02
AU2251183A (en) 1984-11-15
JPS6041609A (ja) 1985-03-05
DK99784D0 (da) 1984-02-24
SE8402512L (sv) 1984-11-12
AU566110B2 (en) 1987-10-08
IL71727A (en) 1989-01-31
CA1222950A (en) 1987-06-16
SE8402512D0 (sv) 1984-05-09
GB2140687B (en) 1987-03-18
FR2545721A1 (fr) 1984-11-16
GB2140687A (en) 1984-12-05
DK163910B (da) 1992-04-21
IT8467283A0 (it) 1984-03-23
IE840010L (en) 1984-11-11
ES532018A0 (es) 1985-03-01
NL192250B (nl) 1996-12-02
NZ206600A (en) 1987-01-23
MX163518B (es) 1992-05-25
NO170834B (no) 1992-09-07
NL8401470A (nl) 1984-12-03
IT8467283A1 (it) 1985-09-23
BE898819A (fr) 1984-05-30
CH669329A5 (enrdf_load_stackoverflow) 1989-03-15
ZA842422B (en) 1984-11-28
NO170834C (no) 1992-12-16
IE56515B1 (en) 1991-08-28
SE455918B (sv) 1988-08-22
ATA88084A (de) 1993-07-15
NL192250C (nl) 1997-04-03
IL71727A0 (en) 1984-09-30
FR2545721B1 (fr) 1987-11-06

Similar Documents

Publication Publication Date Title
ES8503503A1 (es) Un dispositivo para liberar a una velocidad controlada un agente beneficioso a un medio de uso
ES8503499A1 (es) Dispositivo osmotico
USD276766S (en) Chair
IE882641L (en) Dosage form.
ZA907180B (en) Implantable delivery dispenser
Smith et al. Review of neutrophil adherence, chemotaxis, phagocytosis and killing
EP0082182A4 (en) COMPOSITION CONTAINING EMOSTATIC AGENT FACTOR VII A AND METHOD FOR THE PRODUCTION THEREOF.
EP0203186A4 (en) MEDICATION DELIVERY APPARATUS FOR PREVENTING SYSTEMIC TOXICITY AND LOCAL TOXICITY.
ES282407U (es) Una capsula osmotica para la liberacion a velocidad controlada de una formulacion de un agente util
ES8802113A1 (es) Metodo de fabricacion de un nuevo sistema distribuidor para la descarga a velocidad controlada de farmacos beneficiosos
USD274444S (en) Toy building block
GR3024468T3 (en) Inhalation powder containing antistatic agent.
ZA813624B (en) Gravity-feed storage and delivery system
USD270856S (en) Holding tank for a boat or the like
EP0287210A3 (en) Therapeutic compositions
AU8462282A (en) 5 asa drug delivery system
USD278805S (en) Earclip
USD264892S (en) Tie or similar article
AU8539082A (en) Azabicyclo(3,2,1)octyl and (3,3,1) nonyl benzamides
USD293156S (en) Bathing suit or the like
EP0204831A4 (en) ADMINISTRATION SYSTEM FOR MEDICINAL PRODUCTS.
AU5848386A (en) Agent delivery systems
AU550096B2 (en) Dibenzo-1,4-dioxepins and their thia analogues
AU537214B2 (en) 1,1-alkanediol-penicilin derivatives and analogues
IT8468196A1 (it) Dispositivo osmotico e procedimento per l'erogazione di un agente benefico, particolarmente di un farmaco ad un ambiente d'uso.